You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | 3.7% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -20.0 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 12.1 |
Price / Book value | 25.9 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 0.03 | -11.14 | -4.36p | -3.2 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -2.93 | -0.99p | -15.4 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -5.87 | -1.83p | -21.5 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | n/a | -6.87 | -2.03p | -25.2 | 0.0 | n/a | n/a | 0.0% |
Futura has 'transformational year' in 2023 Sharecast News | 06 Feb |
---|---|
Futura Medical extends agreement with Cooper Consumer Health Sharecast News | 15 Jan |
Futura Medical wins European patent for erectile dysfunction gel Sharecast News | 02 Oct |
Notice of Results and Investor Presentation | 25-Mar-24 07:00 |
---|---|
Trading Update | 06-Feb-24 07:01 |
Appointment of Joint Corporate Broker | 06-Feb-24 07:00 |
Director/PDMR Dealing | 17-Jan-24 07:00 |
Remuneration of Non-Exec Directors & Voting Rights | 17-Jan-24 07:00 |